Women with breast cancer who take the antidepressant paroxetine at the same time as tamoxifen are at an increased risk of death, concludes a new study.

Read the original here:
Popular antidepressant blocks the beneficial effects of tamoxifen in breast cancer (Science Daily)

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort studyWomen with breast cancer who take the antidepressant paroxetine at the same time as tamoxifen are at an increased risk of death, concludes a study published on bmj.com Feb.

Read more from the original source:
Popular Antidepressant Blocks Beneficial Effects Of Tamoxifen In Breast Cancer (redOrbit)

Overexpression of low-molecular-weight (LMW-E) forms of the protein cyclin E renders the aromatase inhibitor letrozole ineffective among women with estrogen-receptor-positive (ER+) breast cancers, researchers from The University of Texas M.

Original post:
Low Forms Of Cyclin E Reduce Breast Cancer Drug’s Effectiveness (Medical News Today)

Meg McArthur, from Breakthrough Breast Cancer, said: “It is encouraging to see that a patient’s experience of breast cancer treatment can be improved, with no apparent increase in side effects. Radiotherapy is important in reducing the chance of cancer coming back but women have told Breakthrough that attending many sessions can be both physically and emotionally draining. Anything that has the …

See the original post: 
Comment From Breakthrough Breast Cancer Re Lancet Oncolgy Research, UK (Medical News Today)

Women with breast cancer who take the antidepressant paroxetine at the same time as tamoxifen are at an increased risk of death, concludes a study published on bmj.com today.

See the rest here:
Breast cancer patients taking antidepressant paroxetine at the same time as tamoxifen are at increased risk of death (News-Medical-Net)